Abstract
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder. The HD gene encodes the huntingtin protein (HTT) that contains polyglutamine tracts of variable length. Expansions of the CAG repeat near the amino terminus to encode 40 or more glutamines (polyQ) lead to disease. At least eight other expanded polyQ diseases have been described [1]. HD can be faithfully modeled in Drosophila with the key features of the disease such as late onset, slowly progressing degeneration, formation of abnormal protein aggregates and the dependence on polyQ length being evident. Such invertebrate model organisms provide powerful platforms to explore neurodegenerative mechanisms and to productively speed the identification of targets and agents that are likely to be effective at treating diseases in humans. Here we describe an optical pseudopupil method that can be readily quantified to provide a fast and sensitive assay for assessing the degree of HD neurodegeneration in vivo. We discuss detailed crossing schemes as well as factors including different drivers, various constructs, the number of UAS sites, genetic background, and temperature that can influence the result of pseudopupil measurements.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Paulson HL, Bonini NM, Roth KA (2000) Polyglutamine disease and neuronal cell death. Proc Natl Acad Sci USA 97(24):12957–12958. doi:10.1073/pnas.210395797 210395797 [pii]
Gatchel JR, Zoghbi HY (2005) Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6(10):743–755. doi:nrg1691 [pii] 10.1038/nrg1691
Macdonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N, Macfarlane H, Jenkins B, Anderson MA, Wexler NS, Gusella JF, Bates GP, Baxendale S, Hummerich H, Kirby S, North M, Youngman S, Mott R, Zehetner G, Sedlacek Z, Poustka A, Frischauf AM, Lehrach H, Buckler AJ, Church D, Doucettestamm L, Odonovan MC, Ribaramirez L, Shah M, Stanton VP, Strobel SA, Draths KM, Wales JL, Dervan P, Housman DE, Altherr M, Shiang R, Thompson L, Fielder T, Wasmuth JJ, Tagle D, Valdes J, Elmer L, Allard M, Castilla L, Swaroop M, Blanchard K, Collins FS, Snell R, Holloway T, Gillespie K, Datson N, Shaw D, Harper PS (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtons-disease chromosomes. Cell 72(6):971–983
Gusella JF, Macdonald ME (1995) Huntingtons-disease. Semin Cell Biol 6(1):21–28
Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, Squitieri F, Lin BY, Bassett A, Almqvist E, Bird TD, Hayden MR (1994) A worldwide study of the Huntingtons-disease mutation—the sensitivity and specificity of measuring Cag repeats. N Engl J Med 330(20):1401–1406
Nagai Y, Fujikake N, Ohno K, Higashiyama H, Popiel HA, Rahadian J, Yamaguchi M, Strittmatter WJ, Burke JR, Toda T (2003) Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila. Hum Mol Genet 12(11):1253–1259
Jackson GR, Salecker I, Dong XZ, Yao X, Arnheim N, Faber PW, MacDonald ME, Zipursky SL (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21(3):633–642
Marsh JL, Walker H, Theisen H, Zhu YZ, Fielder T, Purcell J, Thompson LM (2000) Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum Mol Genet 9(1):13–25
Warrick JM, Paulson HL, Gray-Board GL, Bui QT, Fischbeck KH, Pittman RN, Bonini NM (1998) Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93(6):939–949
Kazemi-Esfarjani P, Benzer S (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science 287(5459):1837–1840. doi:8327 [pii]
Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, Kurokawa R, Housman DE, Jackson GR, Marsh JL, Thompson LM (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413(6857):739–743
Lee WCM, Yoshihara M, Littleton JT (2004) Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington’s disease. Proc Natl Acad Sci USA 101(9):3224–3229
Zhang S, Binari R, Zhou R, Perrimon N (2010) A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 184(4):1165–1179. doi:genetics.109.112516 [pii] 10.1534/genetics.109.112516
Romero E, Cha GH, Verstreken P, Ly CV, Hughes RE, Bellen HJ, Botas J (2008) Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron 57(1):27–40. doi:S0896-6273(07)00985-3 [pii] 10.1016/j.neuron.2007.11.025
Mugat B, Parmentier ML, Bonneaud N, Chan HY, Maschat F (2008) Protective role of Engrailed in a Drosophila model of Huntington’s disease. Hum Mol Genet 17(22):3601–3616. doi:ddn255 [pii] 10.1093/hmg/ddn255
Franceschini N (1972) Information processing in the visual systems of arthropods. Springer, Berlin
Agrawal N, Pallos J, Slepko N, Apostol BL, Bodai L, Chang LW, Chiang AS, Thompson LM, Marsh JL (2005) Identification of combinatorial drug regimens for treatment of Huntington’s disease using Drosophila. Proc Natl Acad Sci USA 102(10):3777–3781. doi:10.1073/Pnas.0500055102
Brand AH, Perrimon N (1993) Targeted gene-expression as a means of altering cell fates and generating dominant phenotypes. Development 118(2):401–415
Marsh JL, Thompson LM (2004) Can flies help humans treat neurodegenerative diseases? Bioessays 26(5):485–496. doi:10.1002/Bies.20029
Lin DM, Goodman CS (1994) Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron 13(3):507–523. doi:0896-6273(94)90022-1 [pii]
Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, McCall A, Canal I, Orr HT, Zoghbi HY, Botas J (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408(6808):101–106
Karpilow JM, Pimentel AC, Shamloula HK, Venkatesh TR (1996) Neuronal development in the Drosophila compound eye: photoreceptor cells R1, R6, and R7 fail to differentiate in the Retina aberrant in pattern (rap) mutant. J Neurobiol 31(2):149–165
Spradling AC, Rubin GM (1983) The effect of chromosomal position on the expression of the Drosophila xanthine dehydrogenase gene. Cell 34(1):47–57
Groth AC, Fish M, Nusse R, Calos MP (2004) Construction of transgenic Drosophila by using the site-specific integrase from phage phi C31. Genetics 166(4):1775–1782
Duffy JB (2002) GAL4 system in Drosophila: a fly geneticist’s Swiss army knife. Genesis 34(1–2):1–15. doi:10.1002/Gene.1015
Matsumoto K, Tohe A, Oshima Y (1978) Genetic-control of galactokinase synthesis in Saccharomyces cerevisiae—evidence for constitutive expression of positive regulatory gene Gal4. J Bacteriol 134(2):446–457
Elliott DA, Brand AH (2008) The GAL4 system: a versatile system for the expression of genes. Methods Mol Biol 420:79–95. doi:10.1007/978-1-59745-583-1_5
McGuire SE, Le PT, Osborn AJ, Matsumoto K, Davis RL (2003) Spatiotemporal rescue of memory dysfunction in Drosophila. Science 302(5651):1765–1768
Ito K, Awano W, Suzuki K, Hiromi Y, Yamamoto D (1997) The Drosophila mushroom body is a quadruple structure of clonal units each of which contains a virtually identical set of neurones and glial cells. Development 124(4):761–771
Pignoni F, Zipursky SL (1997) Induction of Drosophila eye development by Decapentaplegic. Development 124(2):271–278
Osterwalder T, Yoon KS, White BH, Keshishian H (2001) A conditional tissue-specific transgene expression system using inducible GAL4. Proc Natl Acad Sci USA 98(22):12596–12601
Roman G, Endo K, Zong L, Davis RL (2001) P{Switch}, a system for spatial and temporal control of gene expression in Drosophila melanogaster. Proc Natl Acad Sci USA 98(22):12602–12607
Rorth P, Szabo K, Bailey A, Laverty T, Rehm J, Rubin GM, Weigmann K, Milan M, Benes V, Ansorge W, Cohen SM (1998) Systematic gain-of-function genetics in Drosophila. Development 125(6):1049–1057
Rorth P (1996) A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Proc Natl Acad Sci USA 93(22):12418–12422
Ando R, Hama H, Yamamoto-Hino M, Mizuno H, Miyawaki A (2002) An optical marker based on the UV-induced green-to-red photoconversion of a fluorescent protein. Proc Natl Acad Sci USA 99(20):12651–12656. doi:10.1073/Pnas.202320599
Ni JQ, Liu LP, Binari R, Hardy R, Shim HS, Cavallaro A, Booker M, Pfeiffer BD, Markstein M, Wang H, Villalta C, Laverty TR, Perkins LA, Perrimon N (2009) A Drosophila resource of transgenic RNAi lines for neurogenetics. Genetics 182(4):1089–1100. doi:10.1534/Genetics.109.103630
Pfeiffer BD, Ngo TTB, Hibbard KL, Murphy C, Jenett A, Truman JW, Rubin GM (2010) Refinement of tools for targeted gene expression in Drosophila. Genetics 186(2):735–755. doi:10.1534/Genetics.110.119917
Robinow S, White K (1988) The locus elav of Drosophila melanogaster is expressed in neurons at all developmental stages. Dev Biol 126(2):294–303
Lee WC, Yoshihara M, Littleton JT (2004) Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington’s disease. Proc Natl Acad Sci USA 101(9):3224–3229. doi:10.1534/Genetics.110.119917
Bonini NM, Fortini ME (2003) Human neurodegenerative disease modeling using Drosophila. Annu Rev Neurosci 26:627–656. doi:10.1146/annurev.neuro.26.041002.131425 041002.131425 [pii]
Ellis MC, Oneill EM, Rubin GM (1993) Expression of Drosophila glass protein and evidence for negative regulation of its activity in nonneuronal cells by another DNA-binding protein. Development 119(3):855–865
Sang TK, Li C, Liu W, Rodriguez A, Abrams JM, Zipursky SL, Jackson GR (2005) Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis. Hum Mol Genet 14(3):357–372. doi:ddi032 [pii] 10.1093/hmg/ddi032
Kirschfeld K, Feiler R, Franceschini N (1978) Photo-stable pigment within rhabdomere of fly photoreceptors No 7. J Comp Physiol 125(3):275–284
Chyb S, Hevers W, Forte M, Wolfgang WJ, Selinger Z, Hardie RC (1999) Modulation of the light response by cAMP in Drosophila photoreceptors. J Neurosci 19(20):8799–8807
Slepko N, Bhattacharyya AM, Jackson GR, Steffan JS, Marsh JL, Thompson LM, Wetzel R (2006) Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins. Proc Natl Acad Sci USA 103(39):14367–14372. doi:10.1073/Pnas.0602348103
Branco J, Al-Ramahi I, Ukani L, Perez AM, Fernandez-Funez P, Rincon-Limas D, Botas J (2008) Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. Hum Mol Genet 17(3):376–390. doi:ddm315 [pii] 10.1093/hmg/ddm315
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Song, W. et al. (2013). Morphometric Analysis of Huntington’s Disease Neurodegeneration in Drosophila . In: Hatters, D., Hannan, A. (eds) Tandem Repeats in Genes, Proteins, and Disease. Methods in Molecular Biology, vol 1017. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-438-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-62703-438-8_3
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-437-1
Online ISBN: 978-1-62703-438-8
eBook Packages: Springer Protocols